| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4edb0c85e21be1bf4c599e643062b125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f6025831316cf3c8435757cd3f4062d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-62 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 |
| filingDate |
2010-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78852a6fd995ed3334adae2a0f561d04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5436975d3ccdc53259319360bd44d25 |
| publicationDate |
2011-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011083391-A2 |
| titleOfInvention |
Biomarkers for anti-igf-ir cancer therapy |
| abstract |
The present invention relates to use of free IGF-1 and the ratio of insulin/IGFBP in the blood as biomarkers for IGF-1 R antagonist therapy for cancer and to method for treating cancer with an IGF-1 R therapy in patients selected based on such biomarkers. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012106556-A2 |
| priorityDate |
2010-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |